What's new

Human medicines European public assessment report (EPAR): Somavert, pegvisomant, Date of authorisation: 12/11/2002, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Somavert, pegvisomant, Date of authorisation: 12/11/2002, Revision: 29, Status: Authorised

Feb 27, 2025 - 09:40
 0
Human medicines European public assessment report (EPAR): Somavert, pegvisomant, Date of authorisation: 12/11/2002, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Somavert, pegvisomant, Date of authorisation: 12/11/2002, Revision: 29, Status: Authorised
Read More

Tags:

Previous Article

Kia PV5 redefines mobility through flexible design and innovative solutions at K...

Next Article

Drax power plant owner lands record £1bn profits amid biomass row

Related Posts

European Shortages Monitoring Platform (ESMP): Implemen...

Mar 10, 2025  0

Orphan designation: bexmarilimab Treatment of myelodysplastic syndromes, 25/03/2025 Positive

Orphan designation: bexmarilimab Treatment of myelodysp...

Apr 4, 2025  0

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 20, 2025  0